Contact
Please use this form to send email to PR contact of this press release:
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
TO:
Please use this form to send email to PR contact of this press release:
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
TO: